Pelthos Therapeutics Inc. (PTHS)
Market Closed
1 Sep, 19:59
AMEX AMEX Primary $
24. 52
+0.44
+1.8272%
$
86.89M Market Cap
- P/E Ratio
- Div Yield
17,965 Volume
- Eps
$ 24.08
Previous Close 
Want to track PTHS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Pelthos Therapeutics Inc. (PTHS) Statistics
Valuation metrics
Market Cap 86.89M
Enterprise value 134.5M
Trailing P/E (ttm) -0.59
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 1.98
Price/Book (mrq) -58.32
Enterprise Value/Revenue 3.11
Enterprise Value/EBITDA -2.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 41.13K
Average volume (90 days) 104.45K
Price summary
52-Week low 18.19
52-Week high 37.5
Beta -
50-Day moving average 26.16
200-Day moving average 23.86
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 2 Jul 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.65%
Operating margin -1.33%
Operational effectiveness
Return on assets -0.52%
Return on equity -2.19%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 12.23
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -20.22
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.94
Total debt (mrq) -
Total Debt/Equity (mrq) -48.71
Current ratio (mrq) 1.98%
Book value per share (mrq) -0.42
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
